Letter by Gallucci and Storto Regarding Article, “Vascular Toxicities of Cancer Therapies: The Old and the New–An Evolving Avenue”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We were particularly impressed by the recent article, vascular toxicities of cancer therapies.1 We agree on the importance of a careful baseline evaluation of cancer patients by cardiooncologists to quantify the likelihood of subsequent cardiovascular toxicities. The vulnerability of the endothelium should be considered in defining cardiovascular …